Elmer Joel Millán-Casarrubias

3PUBLICATIONS
8CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 26, 2025
Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer.

Elmer Joel Millan-Casarrubias, Yunia Verónica García-Tejeda, Claudia Haydée González-De la Rosa

|Jan 11, 2025
PRMT5 Inhibitor EPZ015666 Decreases the Viability and Encystment of Entamoeba invadens.

Rigoberto Ortiz-Hernández, Elmer Joel Millán-Casarrubias, Jeni Bolaños

Pageof 1